Common CTIS User Pain Points and Workarounds for RA Teams Common CTIS User Pain Points and Workarounds for RA Teams The Clinical Trial Information System (CTIS) is a crucial component for managing clinical trials in the European Union under the European Clinical Trials Regulation (EU-CTR). As regulatory affairs (RA) professionals navigate this complex system, understanding the common challenges and effective solutions is paramount. This article serves as a detailed regulatory explainer manual, focusing on the CTIS environment, guidelines, and expectations while highlighting the interactions between regulatory affairs, clinical, CMC, labeling, and commercial teams. Regulatory Affairs Context Regulatory affairs compliance is…

How EU-CTR Affects Transparency, Disclosure and Trial Registries How EU-CTR Affects Transparency, Disclosure and Trial Registries The dynamic landscape of pharmaceutical regulatory affairs necessitates a thorough understanding of various regulations and guidelines governing clinical trials. The EU Clinical Trial Regulation (EU-CTR) represents a significant shift toward enhancing transparency, disclosure, and the systematic operation of trial registries within the European Union. This article aims to provide an in-depth exploration of the EU-CTR, its legal basis, and its implications for regulatory affairs and compliance in clinical trials. Context The EU-CTR (Regulation (EU) No 536/2014) became a cornerstone in standardizing clinical trial operations…

Aligning Global Protocols with EU-Specific Requirements and Practices Aligning Global Protocols with EU-Specific Requirements and Practices Context The evolving landscape of clinical trial regulations necessitates that Regulatory Affairs (RA) professionals possess a comprehensive understanding of both global and region-specific requirements. Given the implementation of the Clinical Trials Regulation (EU) No 536/2014, professionals engaged in clinical trial regulatory approvals must adeptly navigate the complexities introduced by the European Union Clinical Trial Information System (CTIS). This article serves as a regulatory explainer manual that delineates the pertinent guidelines and regulatory frameworks, offers insight into agency expectations, and highlights critical decision points that…

Inspection Readiness in an EU-CTR World: What Inspectors Expect Inspection Readiness in an EU-CTR World: What Inspectors Expect Context As the landscape of clinical trials evolves in the European Union with the implementation of the EU Clinical Trials Regulation (EU-CTR), regulatory professionals encounter new challenges regarding inspection readiness. The EU-CTR aims to harmonize the approval processes for clinical trials across EU member states, enhancing patient safety and simplifying the regulatory framework. Regulatory Affairs (RA) teams play a pivotal role in ensuring compliance with the EU-CTR and the associated Clinical Trials Information System (CTIS), which serves as the central hub for…

Using CTIS Metrics and Dashboards to Manage Your EU Trial Portfolio Using CTIS Metrics and Dashboards to Manage Your EU Trial Portfolio Context The European Union Clinical Trial Regulation (EU-CTR) has transformed the landscape of clinical trial applications and oversight in the EU. With the establishment of the Clinical Trials Information System (CTIS), regulatory affairs professionals are now tasked with employing new tools for effectively managing clinical trial portfolios. A comprehensive understanding of CTIS metrics and dashboards is essential for ensuring efficient compliance with regulations and optimizing clinical trial outcomes. This article serves as a regulatory explainer manual to guide…

Governance Models for Sponsors to Control Quality in CTIS Submissions Governance Models for Sponsors to Control Quality in CTIS Submissions Context The implementation of the EU Clinical Trial Regulation (EU-CTR) and the Clinical Trials Information System (CTIS) represents a pivotal shift in clinical trial conduct across the European Union. This evolution necessitates that sponsors adopt robust governance models to ensure compliance and maintain the integrity of clinical trial submissions. Specifically, it impacts how sponsors manage pharmacovigilance, data submissions, and the overarching regulatory strategies to navigate the approval landscape in Europe. Legal/Regulatory Basis EU Clinical Trial Regulation (EU-CTR) The primary legal…

Case Studies: Early-Adopter Experiences with EU-CTR and CTIS Case Studies: Early-Adopter Experiences with EU-CTR and CTIS The European Union Clinical Trials Regulation (EU-CTR) marks a significant shift in the regulatory landscape for clinical trials across Europe. As the new regulatory framework is implemented, many organizations are grappling with the nuances of the regulation and its interaction with the Clinical Trials Information System (CTIS). This article provides a comprehensive overview of the regulatory expectations stemming from the EU-CTR and the CTIS, elucidates the experiences of early-adopters, and serves as a guiding manual for Regulatory Affairs (RA) professionals navigating this new terrain….

Impact of EU-CTR on Start-Up Timelines Compared with Pre-CTR Era Impact of EU-CTR on Start-Up Timelines Compared with Pre-CTR Era The European Union Clinical Trial Regulation (EU-CTR) significantly reshapes the landscape for initiating clinical trials within the EU. Transitioning from the previous Clinical Trial Directive to the EU-CTR, the regulation aims to unify and streamline the approval process across member states, impacting start-up timelines and regulatory strategies for pharmaceutical companies. This article provides a comprehensive overview of the regulatory framework, implications for pharmacovigilance systems, and the essential considerations for regulatory affairs (RA) professionals navigating this new landscape. Regulatory Context The…

Training Sites and Investigators on EU-CTR-Driven Changes Training Sites and Investigators on EU-CTR-Driven Changes Context The European Union Clinical Trials Regulation (EU-CTR) represents a significant shift in the way clinical trials are managed and conducted within the EU. Established to streamline processes while enhancing patient safety and data integrity, the regulation necessitates compliance with comprehensive guidelines for clinical trial applications (CTAs). Regulatory Affairs (RA) professionals must ensure that their teams, particularly sites and investigators, are well-informed and equipped to navigate these changes. In this regulatory explainer manual, we discuss the implications of EU-CTR on training for clinical trial sites and…

Strategic Considerations for Locating Key Trials in an EU-CTR Environment Strategic Considerations for Locating Key Trials in an EU-CTR Environment The European Union Clinical Trial Regulation (EU-CTR) is essential for pharmaceutical companies and regulatory affairs professionals involved in clinical trials. Understanding the regulatory landscape, requirements, and expectations can facilitate efficient trial planning, enhance regulatory compliance, and ultimately lead to successful clinical trial regulatory approvals. This article serves as a comprehensive manual on the strategic considerations for locating key trials within the EU-CTR environment and emphasizes the importance of regulatory compliance consulting services in navigating this complex framework. Context The EU-CTR…